260 related articles for article (PubMed ID: 20002079)
1. New central targets for the treatment of obesity.
Sargent BJ; Moore NA
Br J Clin Pharmacol; 2009 Dec; 68(6):852-60. PubMed ID: 20002079
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacological therapy of obesity].
Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of appetite suppression: implication for the treatment of obesity.
Halford JC
Curr Drug Targets; 2001 Dec; 2(4):353-70. PubMed ID: 11732637
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic management of obesity.
Kushner RF
Pediatr Blood Cancer; 2012 Jan; 58(1):140-3. PubMed ID: 22009632
[TBL] [Abstract][Full Text] [Related]
5. Central and peripheral molecular targets for antiobesity pharmacotherapy.
Valentino MA; Lin JE; Waldman SA
Clin Pharmacol Ther; 2010 Jun; 87(6):652-62. PubMed ID: 20445536
[TBL] [Abstract][Full Text] [Related]
6. Drug strategies for the treatment of obesity.
Alemany M; Remesar X; Fernández-López JA
IDrugs; 2003 Jun; 6(6):566-72. PubMed ID: 12811679
[TBL] [Abstract][Full Text] [Related]
7. Central nervous system biogenic amine targets for control of appetite and energy expenditure.
Nelson DL; Gehlert DR
Endocrine; 2006 Feb; 29(1):49-60. PubMed ID: 16622292
[TBL] [Abstract][Full Text] [Related]
8. New pharmacological directions for the treatment of overweight and obesity.
Van Gaal LF; Peiffer FW; De Leeuw IH
Acta Clin Belg; 1999 Jun; 54(3):141-6. PubMed ID: 10443041
[No Abstract] [Full Text] [Related]
9. Strategies and potential molecular targets for obesity treatment.
Campfield LA; Smith FJ; Burn P
Science; 1998 May; 280(5368):1383-7. PubMed ID: 9603722
[TBL] [Abstract][Full Text] [Related]
10. Obesity drugs in clinical development.
Halford JC
Curr Opin Investig Drugs; 2006 Apr; 7(4):312-8. PubMed ID: 16625817
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy for childhood obesity: present and future prospects.
Sherafat-Kazemzadeh R; Yanovski SZ; Yanovski JA
Int J Obes (Lond); 2013 Jan; 37(1):1-15. PubMed ID: 22929210
[TBL] [Abstract][Full Text] [Related]
12. The new role of pharmacotherapy for weight reduction in obesity.
Fernstrom MH; Fernstrom JD
Int J Clin Pract; 2002 Nov; 56(9):683-6. PubMed ID: 12469983
[TBL] [Abstract][Full Text] [Related]
13. Serotonin and norepinephrine reuptake inhibition and eating behavior.
Hainer V; Kabrnova K; Aldhoon B; Kunesova M; Wagenknecht M
Ann N Y Acad Sci; 2006 Nov; 1083():252-69. PubMed ID: 17148744
[TBL] [Abstract][Full Text] [Related]
14. Lorcaserin--not a new weapon in the battle with appetite.
Halford JC
Nat Rev Endocrinol; 2010 Dec; 6(12):663-4. PubMed ID: 21102648
[No Abstract] [Full Text] [Related]
15. Pharmacological approaches for the treatment of obesity.
Fernández-López JA; Remesar X; Foz M; Alemany M
Drugs; 2002; 62(6):915-44. PubMed ID: 11929339
[TBL] [Abstract][Full Text] [Related]
16. The discovery and status of sibutramine as an anti-obesity drug.
Luque CA; Rey JA
Eur J Pharmacol; 2002 Apr; 440(2-3):119-28. PubMed ID: 12007530
[TBL] [Abstract][Full Text] [Related]
17. Antiobesity effects of green tea catechins: a mechanistic review.
Rains TM; Agarwal S; Maki KC
J Nutr Biochem; 2011 Jan; 22(1):1-7. PubMed ID: 21115335
[TBL] [Abstract][Full Text] [Related]
18. Drug treatment of obesity.
Bray GA
Rev Endocr Metab Disord; 2001 Oct; 2(4):403-18. PubMed ID: 11725727
[TBL] [Abstract][Full Text] [Related]
19. New advances in models and strategies for developing anti-obesity drugs.
Kim GW; Lin JE; Blomain ES; Waldman SA
Expert Opin Drug Discov; 2013 Jun; 8(6):655-71. PubMed ID: 23621300
[TBL] [Abstract][Full Text] [Related]
20. Safe and effective management of the obese patient.
Collazo-Clavell ML
Mayo Clin Proc; 1999 Dec; 74(12):1255-9; quiz 1259-60. PubMed ID: 10593355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
